Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3

Yi Sun(Nanjing Medical University), Yuncai Zhou(Nanjing Medical University), Ying Shi(Nanjing Medical University), Yan Zhang(Nanjing Medical University), Kerong Liu(Nanjing Medical University), Rui Liang(Nankai University), Peng Sun(Nanjing Medical University), Xiaoai Chang(Nanjing Medical University), Wei Tang(Nanjing Medical University), Yujing Zhang(Nanjing Medical University), Jing Li(Nanjing University), Shusen Wang(Nankai University), Yunxia Zhu(Nanjing Medical University), Xiao Han(Nanjing Medical University)
Cell Reports
January 1, 2021
Cited by 129Open Access
Full Text

Abstract

Type 2 diabetes mellitus (T2DM) is recognized as a chronic, low-grade inflammatory disease characterized by insulin resistance and pancreatic β cell dysfunction; however, the underlying molecular mechanism remains unclear. Here, we report a key β cell-macrophage crosstalk pathway mediated by the miRNA-29-TNF-receptor-associated factor 3 (TRAF3) axis. β cell-specific transgenic miR-29a/b/c mice are predisposed to develop glucose intolerance and insulin resistance when fed a high-fat diet (HFD). The metabolic effect of β cell miR-29 is largely mediated through macrophages because either depletion of macrophages or reconstitution with miR-29-signaling defective bone marrow improves metabolic parameters in the transgenic mice. Mechanistically, our data show that miR-29 promotes the recruitment and activation of circulating monocytes and macrophages and, hence, inflammation, via miR-29 exosomes in a TRAF3-dependent manner. Our results demonstrate the ability of β cells to modulate the systemic inflammatory tone and glucose homeostasis via miR-29 in response to nutrient overload.


Related Papers

No related papers found

Powered by citation graph analysis